Tresiba Injection FlexTouch contains insulin degludec (recombinant), an ultra-long-acting insulin from Novo Nordisk Pharma, used for glycemic control in adults and children with diabetes mellitus. This injectable pen, YJ code 2492419G1021, contains 300 units per kit.
Tresiba Injection FlexTouch
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).